EMMAC Life Sciences PLC: Research Collaboration with Imperial College London

LONDON–(BUSINESS WIRE)–EMMAC, the European independent medical cannabis company, is pleased to
announce a research collaboration with Imperial College London to
deliver a long-term comprehensive research programme designed to inform
and shape the future of the medical cannabis therapeutic industry. The
programme aims to investigate mechanisms of action of cannabis-based
medicinal products related to several clinical applications including
pain and cancer, as well as characterise cannabis-based medicinal
products in disease models with particular focus of chronic pain,
spasticity and cancer.

The initial clinical study, which is currently going through regulatory

... read more at: https://www.businesswire.com/news/home/20190109005712/en/EMMAC-Life-Sciences-PLC-Research-Collaboration-Imperial